Skip to main content
Signal8

Campobasso Matthew

SEC insider (Form 3/4/5 filer). CIK 0002000984. General Counsel at Enfusion, Inc. (ENFN). 8 reported Form 4/5 transactions since Sep 2024; latest on Apr 21, 2025. Located in CHICAGO, IL.

Companies Campobasso Matthew has filed insider reports for

  • Enfusion, Inc. (ENFN): Officer, General Counsel
Campobasso Matthew profile photo

Campobasso Matthew

CIK: 0002000984

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Enfusion, Inc. logo
ENFN

Enfusion, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Enfusion, Inc. logo
    ENFN

    Enfusion, Inc.

    Apr 21, 2025
    Disposition
    Direct
    25.1K shares-
  • Enfusion, Inc. logo
    ENFN

    Enfusion, Inc.

    Apr 21, 2025
    Disposition
    Direct
    45.8K shares-
  • Enfusion, Inc. logo
    ENFN

    Enfusion, Inc.

    Mar 5, 2025
    Sale
    Direct
    1.7K shares at avg. $11.38$19K
  • Enfusion, Inc. logo
    ENFN

    Enfusion, Inc.

    Mar 3, 2025
    Sale
    Direct
    1.1K shares at avg. $11.48$12K
  • Enfusion, Inc. logo
    ENFN

    Enfusion, Inc.

    Feb 26, 2025
    Award
    Direct
    17.6K shares-
  • Enfusion, Inc. logo
    ENFN

    Enfusion, Inc.

    Feb 26, 2025
    Award
    Direct
    3.4K shares-
  • Enfusion, Inc. logo
    ENFN

    Enfusion, Inc.

    Jan 7, 2025
    Sale
    Direct
    976 shares at avg. $10.13$10K
  • Enfusion, Inc. logo
    ENFN

    Enfusion, Inc.

    Oct 22, 2024
    Sale
    Direct
    674 shares at avg. $8.95$6K

1-8 of 8